Skip to content

Clinical trials

Carcinoma, Hepatocellular trials in the United States with unknown status

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Hepatocellular Status: Unknown status Country / region: United States Clear all

29 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20021
20041
20071
20081
20091
20102
20111
20121
20142
20151
20162
20171
20182
20193
20201
20213
20221
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status29

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Peking Union Medical College Hospital2
Rutgers, The State University of New Jersey2
Alexander Kim1
Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)1
American College of Radiology Imaging Network1
Andrea Branch1
Aronex Pharmaceuticals1
Ashwin Somasundaram1
Brown University1
Carisma Therapeutics Inc1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Hepatocellular29
Liver Neoplasms11
Colorectal Neoplasms6
Breast Neoplasms5
Neoplasm Metastasis5
Ovarian Neoplasms5
Pancreatic Neoplasms5
Melanoma4
Neoplasms4
Stomach Neoplasms4

Trials

Showing 1 to 25 of 29. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.